Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 3

Conditions

Hemangioma 9Melanoma 6Hemangioma, Capillary 6Breast Neoplasms 5Sarcoma 3Hemangiosarcoma 3Fallopian Tube Neoplasms 3Urinary Bladder Neoplasms 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Multiple Myeloma 2Hemangioma, Cavernous, Central Nervous System 2Carcinoma, Ovarian Epithelial 2von Hippel-Lindau Disease 1Uterine Cervical Neoplasms 1Urethral Neoplasms 1Ureteral Neoplasms 1Ulcer 1Tuberous Sclerosis 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Spinal Cord Neoplasms 1Smoldering Multiple Myeloma 1Skin Neoplasms 1Sarcoma, Kaposi 1Recurrent respiratory papillomatosis 1Recurrence 1Papilloma 1Ovarian Neoplasms 1Neuroblastoma 1

Interventions

Paclitaxel 7Doxorubicin 5pembrolizumab 4pazopanib 4Gemcitabine 4Bevacizumab 4durvalumab 3Radiotherapy 3Propranolol 3Docetaxel 3regorafenib 2cemiplimab 2Surveys and Questionnaires 2Sunitinib 2Standard of Care 2Nivolumab 2Ifosfamide 23-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 2zanidatamab 1veliparib 1tucatinib 1trilaciclib 1tremelimumab 1trebananib 1trastuzumab duocarmazine 1talimogene laherparepvec 1talazoparib 1spartalizumab 1sintilimab 1selinexor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Hemangiosarcoma × Propranolol × Clear all
NCT04518124 2023-11-22

Propranolol in Angiosarcoma

The Netherlands Cancer Institute

Phase 2 Completed
14 enrolled
Sarcoma

Hemangiosarcoma

NCT05961761 2023-07-27

PROPANE

Herlev and Gentofte Hospital

Phase 2 Recruiting
80 enrolled
Sarcoma

Hemangiosarcoma, Sarcoma, Histiocytoma, Malignant Fibrous

NCT02732678 2016-04-11

PROPAN

Assistance Publique Hopitaux De Marseille

Phase 1/2 Unknown
24 enrolled
Sarcoma

Hemangiosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡